Skip to main content

Table 1 Formulation of carrier solution with different ratios of Lac-HP-β-CD

From: Dual peptides-modified cationic liposomes for enhanced Lung cancer gene therapy by a gap junction regulating strategy

Formulation

L0

L1

L2

L3

L4

L5

L6

L7

Lactose (%, w/w)

100

80

70

60

40

30

20

0

HP-β-CD (%, w/w)

0

20

30

40

60

70

80

100